BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21629306)

  • 1. Teaming up for biomarker future. Many problems still hinder the use of biomarkers in clinical practice, but new public-private partnerships could improve the situation.
    Rinaldi A
    EMBO Rep; 2011 Jun; 12(6):500-4. PubMed ID: 21629306
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward dynamical systems medicine: personalized and preventive strategies.
    Yan Q
    Per Med; 2017 Sep; 14(5):551-554. PubMed ID: 29754568
    [No Abstract]   [Full Text] [Related]  

  • 3. Lee Hood.
    Hood L
    Nat Biotechnol; 2011 Mar; 29(3):191. PubMed ID: 21390010
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategy: prevention. Unfunded plan seeks public, private partnerships.
    Zigmond J
    Mod Healthc; 2011 Jun; 41(25):10. PubMed ID: 21800777
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradigm change from curative to predictive medicine: novel strategic trends in Europe.
    Golubnitschaja O
    Croat Med J; 2009 Dec; 50(6):596-7. PubMed ID: 20017229
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and translational sciences: at the intersection of molecular and individualized medicine.
    Waldman SA; Terzic A
    Clin Transl Sci; 2008 May; 1(1):6-8. PubMed ID: 20443812
    [No Abstract]   [Full Text] [Related]  

  • 7. Enabling personalized medicine in Europe by the European Commission's funding activities.
    Nimmesgern E; Norstedt I; Draghia-Akli R
    Per Med; 2017 Jul; 14(4):355-365. PubMed ID: 29749834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of artificial intelligence in precision oncology: public-private partnerships including national health agencies as an asset to make it happen.
    Luu VP; Fiorini M; Combes S; Quemeneur E; Bonneville M; Bousquet PJ
    Ann Oncol; 2024 Feb; 35(2):154-158. PubMed ID: 37769849
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventive medicine in 2030.
    Freudenberg N
    Prev Med; 2012 Dec; 55(6):577-8. PubMed ID: 23103593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sector partnerships and public health: challenges and opportunities for addressing obesity and noncommunicable diseases through engagement with the private sector.
    Johnston LM; Finegood DT
    Annu Rev Public Health; 2015 Mar; 36():255-71. PubMed ID: 25581149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Academic Biobanks in Public-Private Partnerships in the European Biobanking and BioMolecular Resources Research Infrastructure Community.
    Hämäläinen I; Törnwall O; Simell B; Zatloukal K; Perola M; van Ommen GB
    Biopreserv Biobank; 2019; 17(1):46-51. PubMed ID: 30499696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emergence of Personalized Health Technology.
    Allen LN; Christie GP
    J Med Internet Res; 2016 May; 18(5):e99. PubMed ID: 27165944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometriosis biomarkers: Will codevelopment in academia-industry partnerships result in new and robust noninvasive diagnostic tests?
    M D'Hooghe T; Fassbender A; F O D; Vanhie A
    Biol Reprod; 2019 Dec; 101(6):1140-1145. PubMed ID: 30715151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker qualification via public-private partnerships.
    Eck SL; Paul SM
    Clin Pharmacol Ther; 2010 Jan; 87(1):21-3. PubMed ID: 20019697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charting Our Future Together: Turning Discovery Science Into Cardiovascular Health.
    Gibbons GH
    Circulation; 2017 Aug; 136(7):615-617. PubMed ID: 28808143
    [No Abstract]   [Full Text] [Related]  

  • 16. Public-private partnerships in translational medicine: concepts and practical examples.
    Luijten PR; van Dongen GA; Moonen CT; Storm G; Crommelin DJ
    J Control Release; 2012 Jul; 161(2):416-21. PubMed ID: 22465390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public-Private Partnerships and Undernutrition: Examples and Future Prospects.
    Hoddinott J; Gillespie S; Yosef S
    World Rev Nutr Diet; 2016; 115():233-8. PubMed ID: 27198661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Civil society participation in global public private partnerships for health.
    Storeng KT; de Bengy Puyvallée A
    Health Policy Plan; 2018 Oct; 33(8):928-936. PubMed ID: 30165606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biomarkers consortium.
    Wholley D
    Nat Rev Drug Discov; 2014 Nov; 13(11):791-2. PubMed ID: 25359363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Achieve Transparency in Public-Private Partnerships Engaged in Hunger and Malnutrition Reduction.
    Eggersdorfer M; Bird JK
    World Rev Nutr Diet; 2016; 115():224-32. PubMed ID: 27198563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.